Last reviewed · How we verify
Dexmedetomidine bolus and high infusion-Propofol
Dexmedetomidine bolus and high infusion-Propofol is a Small molecule drug developed by Joseph Cravero. It is currently FDA-approved. Also known as: Dexmedetomidine-Propofol.
Dexmedetomidine bolus and high infusion-Propofol, marketed by Joseph Cravero, is a combination therapy currently available in the market. The key composition patent is set to expire in 2028, providing a clear period of exclusivity. The primary risk is the potential increase in competition post-patent expiry.
At a glance
| Generic name | Dexmedetomidine bolus and high infusion-Propofol |
|---|---|
| Also known as | Dexmedetomidine-Propofol |
| Sponsor | Joseph Cravero |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging (PHASE4)
- Venous Cannulation Pain to Guide Choice of Anesthetic Method (NA)
- A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging (PHASE4)
- Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans (PHASE4)
- Different Modalities of Analgesia in Open Heart Surgeries in Mansoura University (PHASE4)
- Comparison of Remifentanil and Dexmedetomidine for Monitored Anaesthesia Care During Vertebroplasty and Kyphoplasty (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine bolus and high infusion-Propofol CI brief — competitive landscape report
- Dexmedetomidine bolus and high infusion-Propofol updates RSS · CI watch RSS
- Joseph Cravero portfolio CI
Frequently asked questions about Dexmedetomidine bolus and high infusion-Propofol
What is Dexmedetomidine bolus and high infusion-Propofol?
Who makes Dexmedetomidine bolus and high infusion-Propofol?
Is Dexmedetomidine bolus and high infusion-Propofol also known as anything else?
What development phase is Dexmedetomidine bolus and high infusion-Propofol in?
Related
- Manufacturer: Joseph Cravero — full pipeline
- Also known as: Dexmedetomidine-Propofol
- Compare: Dexmedetomidine bolus and high infusion-Propofol vs similar drugs
- Pricing: Dexmedetomidine bolus and high infusion-Propofol cost, discount & access